Reinherz, Ellis L.
Harvard Medical School,
United States
2025 Rank: 40239
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1224 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40239 | 39261 |
| Total Cites | 17379 | 19843 |
| H-index | 71 | 79 |
| Hm-index | 29 | 32 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 43 | 47 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 1434 | 1529 |
| Number of Single+First+Last Authored Papers | 311 | 311 |
| Total Cites to Single+First+Last Authored Papers | 10737 | 12276 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12973 | 13736 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.44 |
| Self-Citation Percentage |
12.42%
|
|
Reinherz, Ellis L.
Harvard Medical School,
United States
2024 Rank: 39347
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1214 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39347 | 39834 |
| Total Cites | 16612 | 18950 |
| H-index | 69 | 75 |
| Hm-index | 29 | 32 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 37 | 41 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 1386 | 1471 |
| Number of Single+First+Last Authored Papers | 310 | 310 |
| Total Cites to Single+First+Last Authored Papers | 10324 | 11801 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12431 | 13161 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.44 |
| Self-Citation Percentage |
12.34%
|
|
Reinherz, Ellis L.
Harvard Medical School,
United States
2023 Rank: 38369
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1206 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38369 | 38143 |
| Total Cites | 15963 | 18185 |
| H-index | 68 | 75 |
| Hm-index | 29 | 31 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 33 | 36 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 1351 | 1433 |
| Number of Single+First+Last Authored Papers | 305 | 305 |
| Total Cites to Single+First+Last Authored Papers | 9985 | 11402 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11935 | 12626 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.44 |
| Self-Citation Percentage |
12.22%
|
|
Reinherz, Ellis L.
Dana-Farber Cancer Institute,
United States
2022 Rank: 35821
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1170 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35821 | 36357 |
| Total Cites | 15298 | 17478 |
| H-index | 67 | 73 |
| Hm-index | 28 | 30 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 30 | 33 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 1310 | 1392 |
| Number of Single+First+Last Authored Papers | 308 | 308 |
| Total Cites to Single+First+Last Authored Papers | 9627 | 11028 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11423 | 12092 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.45 |
| Self-Citation Percentage |
12.47%
|
|
Reinherz, Ellis L.
Dana-Farber Cancer Institute,
United States
2021 Rank: 36320
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1178 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36320 | 35765 |
| Total Cites | 14880 | 16997 |
| H-index | 65 | 72 |
| Hm-index | 27 | 30 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 27 | 30 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 1270 | 1352 |
| Number of Single+First+Last Authored Papers | 306 | 306 |
| Total Cites to Single+First+Last Authored Papers | 9381 | 10740 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11124 | 11771 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.44 |
| Self-Citation Percentage |
12.46%
|
|
Reinherz, Ellis L.
Harvard Medical School,
United States
2020 Rank: 35122
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1166 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35122 | 35310 |
| Total Cites | 14097 | 16116 |
| H-index | 65 | 71 |
| Hm-index | 27 | 29 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 20 | 23 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 1225 | 1307 |
| Number of Single+First+Last Authored Papers | 305 | 305 |
| Total Cites to Single+First+Last Authored Papers | 8955 | 10258 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10534 | 11150 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.45 |
| Self-Citation Percentage |
12.53%
|
|